GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (BUD:RICHTER) » Definitions » Revenue

Chemical Works of Gedeon Richter (BUD:RICHTER) Revenue

: Ft1,632,030 Mil (TTM As of Dec. 2023)
View and export this data going back to 1994. Start your Free Trial

Chemical Works of Gedeon Richter's revenue for the three months ended in Dec. 2023 was Ft616,614 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was Ft1,632,030 Mil. Chemical Works of Gedeon Richter's Revenue per Share for the three months ended in Dec. 2023 was Ft3,380.50. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was Ft8,850.21.

Warning Sign:

Chemical Works of Gedeon Richter PLC revenue growth has slowed down over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Chemical Works of Gedeon Richter was 1.10% per year. During the past 3 years, the average Revenue per Share Growth Rate was 12.70% per year. During the past 5 years, the average Revenue per Share Growth Rate was 13.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Chemical Works of Gedeon Richter's highest 3-Year average Revenue per Share Growth Rate was 16.40% per year. The lowest was 3.60% per year. And the median was 8.50% per year.


Chemical Works of Gedeon Richter Revenue Historical Data

The historical data trend for Chemical Works of Gedeon Richter's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chemical Works of Gedeon Richter Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 507,794.00 566,776.00 630,595.00 802,755.00 805,158.00

Chemical Works of Gedeon Richter Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 584,948.00 209,653.00 203,783.00 601,980.00 616,614.00

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chemical Works of Gedeon Richter Revenue Distribution

For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's Revenue distribution charts can be found below:

* The bar in red indicates where Chemical Works of Gedeon Richter's Revenue falls into.



Chemical Works of Gedeon Richter Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was Ft1,632,030 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Chemical Works of Gedeon Richter  (BUD:RICHTER) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Chemical Works of Gedeon Richter Revenue Related Terms

Thank you for viewing the detailed overview of Chemical Works of Gedeon Richter's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Chemical Works of Gedeon Richter (BUD:RICHTER) Business Description

Traded in Other Exchanges
Address
Gyomroi ut 19-21, Budapest, HUN, 1103
Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.

Chemical Works of Gedeon Richter (BUD:RICHTER) Headlines

No Headlines